Rare Disease Report

Givosiran and Hepatic Porphyrias

JANUARY 11, 2017
Pushkal Garg, MD



Pushkal Garg, MD, of Alnylam Pharmaceuticals discusses the recent data on the efficacy and safety of givosiran to treat hepatic porphyrias. 
 
The data discussed was presented at the  ASH Annual Meeting & Exposition recently held in San Diego, CA.


Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.